Cancer-Targeting Compound 1

• Description:

  Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  299.35

• Molecular Formula:

  C15H13N3O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1007581-62-5